Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer

Lee,Wan-Sik; Park,Young-Lan; Kim,Nuri; Oh,Hyung-Hoon; Son,Dong-Jun; Kim,Mi-Young; Oak,Chan-Young; Chung,Cho-Yun; Park,Hyung-Chul; Kim,Jong-Sun; Myung,Dae-Seong; Cho,Sung-Bum; Joo,Young-Eun

doi:10.3892/ijo.2015.2890

Myeloid cell leukemia-1 regulates the cell growth and predicts prognosis in gastric cancer

Authors:
- Wan-Sik Lee
- Young-Lan Park
- Nuri Kim
- Hyung-Hoon Oh
- Dong-Jun Son
- Mi-Young Kim
- Chan-Young Oak
- Cho-Yun Chung
- Hyung-Chul Park
- Jong-Sun Kim
- Dae-Seong Myung
- Sung-Bum Cho
- Young-Eun Joo
View Affiliations

Affiliations: Department of Internal Medicine, Chonnam National University Medical School, Dong-ku, Gwangju 501-757, Republic of Korea
Published online on: February 10, 2015 https://doi.org/10.3892/ijo.2015.2890
Pages: 2154-2162

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression of myeloid cell leukemia-1 (Mcl‑1), a member of the anti-apoptotic Bcl-2 protein family, has been associated with tumor progression and adverse patient outcome. The aims of current study were to evaluate whether Mcl-1 affects the survival or death of gastric cancer cells, and to investigate the prognostic value of its expression in gastric cancer. PcDNA3.1-Mcl-1 expression and Mcl-1 siRNA vectors were used to overexpress and silence Mcl-1 expression in gastric cancer cell lines including SNU638 and TMK1, respectively. Immunohistochemistry was used to determine the expression of Mcl-1 in gastric cancer tissues. Apoptosis was determined by the TUNEL assay, and cell proliferation was determined by immunostaining with a Ki-67 antibody. Mcl-1 knockdown induced apoptosis through the upregulation of caspase-3, and -7, and PARP activity, and the release of Smac/DIABLO and Omi/HtrA2 into the cytoplasm. Additionally, cell cycle arrest occurred due to decrease of cyclin D1, cell division cycle gene 2 (cdc2), and cyclin-dependent kinase 4 and 6. In contrast, overexpression of Mcl-1 inhibited apoptosis and cell cycle arrest. Mcl-1 knockdown did not suppress tumor cell proliferation in gastric cancer cells, whereas overexpression of Mcl-1 enhanced tumor cell proliferation. The JAK2 and STAT3 signaling cascades were significantly blocked by Mcl-1 knockdown. The mean Ki-67 labeling index (KI) value of Mcl-1 positive tumors was significantly lower than that of Mcl-1 negative tumors. However, there was no significant difference between Mcl-1 expression and the apoptotic index (AI). Mcl-1 expression was significantly increased in gastric cancer tissues compared to normal gastric mucosa tissues, and was associated with age, tumor size, stage, depth of invasion, lymph node metastasis and poor survival. Our study showed that Mcl-1 regulates the cell growth and might be a potential prognostic marker for gastric cancer.

View Figures

View References

1	Guggenheim DE and Shah MA: Gastric cancer epidemiology and risk factors. J Surg Oncol. 107:230–236. 2013. View Article : Google Scholar
2	Krejs GJ: Gastric cancer: Epidemiology and risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
3	Allan AL, Vantyghem SA, Tuck AB and Chambers AF: Tumor dormancy and cancer stem cells: Implications for the biology and treatment of breast cancer metastasis. Breast Dis. 26:87–98. 2007.PubMed/NCBI
4	Brábek J, Mierke CT, Rösel D, Veselý P and Fabry B: The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal. 8:222010. View Article : Google Scholar : PubMed/NCBI
5	Chaffer CL and Weinberg RA: A perspective on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
6	Kiechle FLand Zhang X: Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta. 326:27–45. 2002. View Article : Google Scholar
7	Schultz DR and Harrington WJ Jr: Apoptosis: Programmed cell death at a molecular level. Semin Arthritis Rheum. 32:345–369. 2003. View Article : Google Scholar : PubMed/NCBI
8	Ola MS, Nawaz M and Ahsan H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
9	Llambi F and Green DR: Apoptosis and oncogenesis: Give and take in the BCL-2 family. Curr Opin Genet Dev. 21:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
10	Weyhenmeyer B, Murphy AC, Prehn JH and Murphy BM: Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer. Exp Oncol. 34:192–199. 2012.PubMed/NCBI
11	Davids MS and Letai A: Targeting the B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol. 30:3127–3135. 2012. View Article : Google Scholar : PubMed/NCBI
12	Thomas LW, Lam C and Edwards SW: Mcl-1; the molecular regulation of protein function. FEBS Lett. 584:2981–2989. 2010. View Article : Google Scholar : PubMed/NCBI
13	Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 66:1326–1336. 2009. View Article : Google Scholar
14	Quinn BA, Dash R, Azab B, et al: Targeting Mcl-1 for the therapy of cancer. Expert Opin Investig Drugs. 20:1397–1411. 2011. View Article : Google Scholar : PubMed/NCBI
15	Zhang T, Zhao C, Luo L, Zhao H, Cheng J and Xu F: The expression of Mcl-1 in human cervical cancer and its clinical significance. Med Oncol. 29:1985–1991. 2012. View Article : Google Scholar
16	Luo L, Zhang T, Liu H, Lv T, Yuan D, Yao Y, Lv Y and Song Y: MiR-101 and Mcl-1 in non-small-cell lung cancer: Expression profile and clinical significance. Med Oncol. 29:1681–1686. 2012. View Article : Google Scholar
17	Henderson-Jackson EB, Helm J, Ghayouri M, Hakam A, Nasir A, Leon M, Bui M, Yeatman T and Coppola D: Correlation between Mcl-1 and pAKT protein expression in colorectal cancer. Int J Clin Exp Pathol. 3:768–774. 2010.PubMed/NCBI
18	Likui W, Qun L, Wanqing Z, Haifeng S, Fangqiu L and Xiaojun L: Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer. J Surg Oncol. 100:396–400. 2009. View Article : Google Scholar : PubMed/NCBI
19	Maeta Y, Tsujitani S, Matsumoto S, et al: Expression of Mcl-1 and p53 proteins predicts the survival of patients with T3 gastric carcinoma. Gastric Cancer. 7:78–84. 2004. View Article : Google Scholar : PubMed/NCBI
20	Tsujitani S, Saito H, Wakatsuki T, Ikeguchi M, Shirabe K, Morita M, Kakeji Y, Yano T and Maehara Y: Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer. Surg Today. 42:225–232. 2012. View Article : Google Scholar
21	Akagi H, Higuchi H, Sumimoto H, et al: Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer. 16:100–110. 2013. View Article : Google Scholar
22	Mandelin AM II and Pope RM: Myeloid cell leukemia-1 as a therapeutic target. Expert Opin Ther Targets. 11:363–373. 2007. View Article : Google Scholar : PubMed/NCBI
23	Perciavalle RM and Opferman JT: Delving deeper: MCL-1’s contributions to normal and cancer biology. Trends Cell Biol. 23:22–29. 2013. View Article : Google Scholar
24	Hartman ML and Czyz M: Anti-apoptotic proteins on guard of melanoma cell survival. Cancer Lett. 331:24–34. 2013. View Article : Google Scholar : PubMed/NCBI
25	Bose P and Grant S: Mcl-1 as a therapeutic target in acute myelogenous leukemia (AML). Leuk Res Rep. 2:12–14. 2013.PubMed/NCBI
26	Frederick L, Greene D and Irvin D: AJCC cancer staging manual. 6th edition. Springer-Verlag; New York: pp. 17–57. 2002
27	Obexer P and Ausserlechner MJ: X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy. Front Oncol. 4:1972014. View Article : Google Scholar : PubMed/NCBI
28	de Almagro MC and Vucic D: The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy. Exp Oncol. 34:200–211. 2012.PubMed/NCBI
29	Kilbride SM and Prehn JH: Central roles of apoptotic proteins in mitochondrial function. Oncogene. 32:2703–2711. 2013. View Article : Google Scholar
30	Graña X and Reddy EP: Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
31	Soták M, Sumová A and Pácha J: Cross-talk between the circadian clock and the cell cycle in cancer. Ann Med. 46:221–232. 2014. View Article : Google Scholar : PubMed/NCBI
32	Fisher D, Krasinska L, Coudreuse D and Novák B: Phosphorylation network dynamics in the control of cell cycle transitions. J Cell Sci. 125:4703–4711. 2012. View Article : Google Scholar : PubMed/NCBI
33	Yu HG, Ai YW, Yu LL, et al: Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death. Int J Cancer. 122:433–443. 2008. View Article : Google Scholar
34	Choi IJ, Kim JS, Kim JM, Jung HC and Song IS: Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun. 71:830–837. 2003. View Article : Google Scholar : PubMed/NCBI
35	McCubrey JA, Steelman LS, Bertrand FE, et al: GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget. 5:2881–2911. 2014.PubMed/NCBI
36	Amoyel M, Anderson AM and Bach EA: JAK/STAT pathway dysregulation in tumors: A Drosophila perspective. Semin Cell Dev Biol. 28:96–103. 2014. View Article : Google Scholar : PubMed/NCBI
37	Wacheck V, Cejka D, Sieghart W, Losert D, Strommer S, Crevenna R, Monia BP and Selzer E: Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cells. Cancer Biol Ther. 5:1348–1354. 2006. View Article : Google Scholar : PubMed/NCBI
38	Zangemeister-Wittke U and Huwiler A: Antisense targeting of Mcl-1 has therapeutic potential in gastric cancer. Cancer Biol Ther. 5:1355–1356. 2006. View Article : Google Scholar : PubMed/NCBI